SCHEMBL16792377

SCHEMBL16792377

C1CN2CCN1CC2.O=C(O)c1cccc(OOCl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.51
KMO O15229 2/20 0.48
NR4A2 P43354 6/20 0.45
KMT2A Q03164 2/20 0.45
POLB P06746 1/20 0.45
MRGPRX4 Q96LA9 1/20 0.44
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
NR4A1 P22736 1/20 0.42
NR4A3 Q92570 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA6 P23280 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL71432 0.90 AKR1C3 (0.61) AKR1C3KMONR4A2KMT2AMRGPRX4
Water SCHEMBL27971095 0.89 AKR1C3 (0.59) AKR1C3KMONR4A2KMT2AMRGPRX4
Toluene SCHEMBL28189299 0.81 AKR1C3 (0.56) AKR1C3KMONR4A2KMT2APOLB
SCHEMBL1941132 0.80 AKR1C3 (0.58) AKR1C3KMONR4A2KMT2AMRGPRX4
SCHEMBL11000519 0.80 AKR1C3 (0.54) AKR1C3KMONR4A2KMT2AMRGPRX4
Ethyl Acetate SCHEMBL5560814 0.77 KMT2A (0.51) AKR1C3KMONR4A2KMT2APOLB
SCHEMBL28598896 0.76 TSHR (0.44) AKR1C3KMONR4A2KMT2AMRGPRX4
SCHEMBL29118338 0.76 AKR1C3 (0.71) AKR1C3KMONR4A2KMT2AMRGPRX4
SCHEMBL30517803 0.76 AKR1C3 (0.66) AKR1C3KMONR4A2KMT2AMRGPRX4
SCHEMBL5235780 0.76 AKR1C3 (0.66) AKR1C3KMONR4A2KMT2AMRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3080115-A1 FUSED IMIDAZOLE AND PYRAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB Biopharma SPRL (BE) 2016-10-19 EP disclosed
WO-2015086506-A1 FUSED IMIDAZOLE AND PYRAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB BIOPHARMA SPRL (BE) 2015-06-18 WO disclosed